View Cart (0 items)

Pharmaceutical

Synta signs potential $1 billion deal with Roche

January 8, 2009
Biotechnology company Synta Pharmaceuticals Corp. could receive more than $1 billion in payments from Roche under a drug development partnership, the company said in a Securities and Exchange Commission filing,
Read More

Melamine byproduct in more U.S. infant formula

January 8, 2009
The Food and Drug Administration says the industrial chemical melamine and a byproduct cyanuric acid have now been detected in four of 89 containers of infant formula made in the
Read More

Novartis acquires license to CMV vaccine candidate

December 30, 2008
The Associated Press reports that Swiss pharmaceutical giant Novartis AG has licensed a potential vaccine for a type of herpes virus from U.S.-based company AlphaVax Inc. Novartis said it is
Read More

Teva acquisition of Barr cleared in US, Europe

December 22, 2008
Teva Pharmaceutical Industries Ltd announced that regulators are ordering the company to divest several generic drugs in order to complete its purchase of rival Barr Pharmaceuticals, according to the Associated
Read More

Johnson & Johnson gets Israel''s approval for acquisition of Omrix

December 16, 2008
The Israeli government has approved Johnson & Johnson''s planned acquisition of business partner Omrix Biopharmaceuticals Inc., a move to boost the health products giant''s surgical care business, according to the
Read More

Pfizer to cut 700 jobs in France

December 16, 2008
The Associated Press reports that Pfizer Inc. will cut 700 jobs in France out of its total French workforce of 3,000 as part of the U.S. drugmaker''s global reorganization. New
Read More

Merck expanding into biotech, emerging markets

December 10, 2008
The Associated Press reports that Merck & Co. is taking steps to become a leader in generic biotechnology drugs and sales in emerging markets, diversifying its research through partnerships and
Read More

EU accuses drugmakers of blocking cheaper generics

December 1, 2008
As reported by Reuters, major drug companies are delaying or blocking the entry of cheaper generic medicines, pushing up bills for taxpayers and reducing the incentive for innovation, the European
Read More

Indonesia requires foreign drug firms to build plants in country or leave

December 1, 2008
Indonesia''s health minister, Siti Fadliah Supari, is confident foreign pharmaceutical companies will comply with new rules requiring them to build local factories, saying they would not risk being locked out
Read More

Pfizer launches global regenerative medicine research unit

November 17, 2008
According to Reuters, Pfizer has announced the launch of a new research unit known as Pfizer Regenerative Medicine. This independent research unit will build on recent scientific progress in understanding
Read More